address1,address2,city,zip,country,phone,fax,website,industry,industryKey,industryDisp,sector,sectorKey,sectorDisp,longBusinessSummary,companyOfficers,compensationAsOfEpochDate,executiveTeam,maxAge,priceHint,previousClose,open,dayLow,dayHigh,regularMarketPreviousClose,regularMarketOpen,regularMarketDayLow,regularMarketDayHigh,dividendRate,dividendYield,exDividendDate,payoutRatio,fiveYearAvgDividendYield,beta,trailingPE,volume,regularMarketVolume,averageVolume,averageVolume10days,averageDailyVolume10Day,bid,ask,bidSize,askSize,marketCap,fiftyTwoWeekLow,fiftyTwoWeekHigh,priceToSalesTrailing12Months,fiftyDayAverage,twoHundredDayAverage,trailingAnnualDividendRate,trailingAnnualDividendYield,currency,tradeable,enterpriseValue,forwardPE,profitMargins,floatShares,sharesOutstanding,heldPercentInsiders,heldPercentInstitutions,impliedSharesOutstanding,bookValue,priceToBook,lastFiscalYearEnd,nextFiscalYearEnd,mostRecentQuarter,earningsQuarterlyGrowth,netIncomeToCommon,trailingEps,lastSplitFactor,lastSplitDate,enterpriseToRevenue,enterpriseToEbitda,52WeekChange,SandP52WeekChange,lastDividendValue,lastDividendDate,quoteType,currentPrice,targetHighPrice,targetLowPrice,targetMeanPrice,targetMedianPrice,recommendationMean,recommendationKey,numberOfAnalystOpinions,totalCash,totalCashPerShare,ebitda,totalDebt,quickRatio,currentRatio,totalRevenue,debtToEquity,revenuePerShare,returnOnAssets,returnOnEquity,grossProfits,freeCashflow,operatingCashflow,earningsGrowth,revenueGrowth,grossMargins,ebitdaMargins,operatingMargins,financialCurrency,symbol,language,region,typeDisp,quoteSourceName,triggerable,customPriceAlertConfidence,marketState,shortName,longName,exchange,messageBoardId,exchangeTimezoneName,exchangeTimezoneShortName,gmtOffSetMilliseconds,market,esgPopulated,regularMarketChangePercent,regularMarketPrice,cryptoTradeable,hasPrePostMarketData,firstTradeDateMilliseconds,regularMarketChange,regularMarketDayRange,fullExchangeName,averageDailyVolume3Month,fiftyTwoWeekLowChange,fiftyTwoWeekLowChangePercent,fiftyTwoWeekRange,fiftyTwoWeekHighChange,fiftyTwoWeekHighChangePercent,fiftyTwoWeekChangePercent,earningsTimestamp,earningsTimestampStart,earningsTimestampEnd,earningsCallTimestampStart,earningsCallTimestampEnd,isEarningsDateEstimate,epsTrailingTwelveMonths,epsCurrentYear,priceEpsCurrentYear,fiftyDayAverageChange,fiftyDayAverageChangePercent,twoHundredDayAverageChange,twoHundredDayAverageChangePercent,sourceInterval,exchangeDataDelayedBy,averageAnalystRating,corporateActions,regularMarketTime,trailingPegRatio
Ashvich Tower,"3rd Floor No.3, Developed Plots Industrial Estate Perungudi",Chennai,600096,India,91 44 2496 8000,91 44 2815 4952,https://www.caplinpoint.net,Drug Manufacturers - Specialty & Generic,drug-manufacturers-specialty-generic,Drug Manufacturers - Specialty & Generic,Healthcare,healthcare,Healthcare,"Caplin Point Laboratories Limited, together with its subsidiaries, engages in the development, production, marketing, and export of generic pharmaceutical formulations and branded products in India. The company provides tablets, capsules, injections, ophthalmic, liquid orals, softgel capsules, ointments, creams and gels, powder for injections, suppositories, ovules, pre-mix bag formulations, inhalers, and sprays and IV infusion. It also provides dry syrups, lyophilized vials, prefilled syringes, emulsion injection, and topicals. Caplin Point Laboratories Limited was incorporated in 1990 and is headquartered in Chennai, India.","[{'maxAge': 1, 'name': 'Dr. Sridhar  Ganesan', 'age': 69, 'title': 'MD & Whole Time Director', 'yearBorn': 1955, 'fiscalYear': 2024, 'totalPay': 9300000, 'exercisedValue': 0, 'unexercisedValue': 0}, {'maxAge': 1, 'name': 'Mr. D.  Muralidharan', 'title': 'Chief Financial Officer', 'fiscalYear': 2024, 'totalPay': 9100000, 'exercisedValue': 0, 'unexercisedValue': 0}, {'maxAge': 1, 'name': 'Mr. Partheeban Vivek Siddarth', 'title': 'Chief Operating officer', 'fiscalYear': 2024, 'exercisedValue': 0, 'unexercisedValue': 0}, {'maxAge': 1, 'name': 'Mr. G.  Venkatram', 'age': 42, 'title': 'General Counsel, Company Secretary & Compliance Officer', 'yearBorn': 1982, 'fiscalYear': 2024, 'totalPay': 6500000, 'exercisedValue': 0, 'unexercisedValue': 0}, {'maxAge': 1, 'name': 'Mr. M. Sathya Narayanan', 'title': 'Deputy Chief Financial Officer', 'fiscalYear': 2024, 'exercisedValue': 0, 'unexercisedValue': 0}, {'maxAge': 1, 'name': 'Mr. Ashok Gorekey Partheeban', 'title': 'Head of Marketing - Latam Business', 'fiscalYear': 2024, 'exercisedValue': 0, 'unexercisedValue': 0}]",1735603200,[],86400,2,2050.0,2054.0,2004.0,2061.7,2050.0,2054.0,2004.0,2061.7,6.0,0.29,1748563200,0.0712,0.43,0.297,29.089874,85286,85286,146491,125301,125301,0.0,0.0,0,0,155489517568,1365.0,2641.0,8.02539,2014.707,2064.067,0.0,0.0,INR,False,148004126720,20.435564,0.27681,19263298,76011696,0.73293996,0.045760002,77441104,365.072,5.603278,1743379200,1774915200,1743379200,0.173,5363100160,70.32,5:1,1476835200,7.639,22.878,0.43996072,0.094471335,3.0,1748563200,EQUITY,2045.6,2516.0,2500.0,2508.0,2508.0,1.0,strong_buy,2,9027399680,118.723,6469300224,50200000,5.011,6.965,19374700544,0.174,254.941,0.12295,0.20679002,11666299904,1474550016,4323700224,0.175,0.104,0.60214,0.3339,0.30056998,INR,CAPLIPOINT.NS,en-US,US,Equity,Delayed Quote,True,HIGH,POSTPOST,CAPLIN POINT LAB LTD.,Caplin Point Laboratories Limited,NSI,finmb_20334103,Asia/Kolkata,IST,19800000,in_market,False,-0.21463534,2045.6,False,False,1403495100000,-4.4000244,2004.0 - 2061.7,NSE,146491,680.6,0.49860805,1365.0 - 2641.0,-595.4,-0.22544491,43.99607,1747306740,1754391540,1754740800,1747305000,1747305000,True,70.32,84.25,24.280119,30.892944,0.015333716,-18.466919,-0.008946861,15,15,1.0 - Strong Buy,[],1750413593,
